Biologics
Category VIEW ALL
Chimeric Fc receptor to augment antibody-based cell therapies
Technology No. 20180040
Synthetic cell line for high-yield rAAV production
Technology No. 2023-257
Antibodies for rapid mycoplasma hyopneumoniae detection
Technology No. 2020-097
Masked nanobodies for targeted cancer therapy
Technology No. 2022-246
Mouse model expressing human APOBEC3B for cancer research
Technology No. 20150120
Method for rapid mechanical profiling of cells
Technology No. 2022-256
Modified myeloid-derived suppressor cells for treating GvHD
Technology No. 20160072
A minipromoter for gene therapies
Technology No. 2023-188
Allogeneic extracellular vesicles for enhancing CD8+ T cell response in colorectal cancer
Technology No. 2023-280
Zika as an oncolytic virus to treat brain tumors
Technology No. 20170095
Hamster CD4 and CD8 antibodies
Technology No. Z09177
Therapeutic target for treatment of ataxia
Technology No. 20160307
Glycoengineered mesenchymal stem cells as targeted therapeutic carriers
Technology No. 20160092
Hyperstable synthetic miniproteins as ligand scaffolds
Technology No. 2023-269
Inhibitory nucleic acid molecules targeting cyclin D1 mRNA
Technology No. 2022-145
Broadspectrum potentially therapeutic nanobodies against COVID-19
Technology No. 2023-140
Nanorings for cell-mediated drug delivery
Technology No. 2022-267
Efficient CRISPR-based gene editing for stem cells
Technology No. 2021-185
Ovarian cancer prognostic test for predicting response to chemotherapy and bevacizumab
Technology No. 20180331
NOD-2-active carboxamide compounds as vaccine adjuvants
Technology No. 2019-001
Lentivirus for keratinocyte immortalization and immortalized keratinocyte cell lines
Technology No. 2020-286
Generating teratoma-derived skeletal muscle stem cells
Technology No. 20160361
Methods for Modifying Proteins and Peptides.
Technology No. 20180338
HUH fusion enzymes for multiplex protein labeling
Technology No. 20150143
Cell-free selection of site-specific polypeptide binders via tethering
Technology No. 20170034
Compound with selective inhibition potential against P300 and CBT
Technology No. 2021-151
Camelid single domain antibody phage display library
Technology No. 2020-220
T cell receptors for engineered T cell therapy
Technology No. 2020-202
Nanominne-1: novel virus-like particle (nanoparticle) vaccines to prevent SARS-CoV-2 infections
Technology No. 2020-372
Targeted Artificial DNA Replisome (TADR) a Tool for Targeted Mutagenesis
Technology No. 2021-073
Engineered SARS-CoV-2 spike ectodomain for COVID-19 diagnostic assays
Technology No. 2021-233
Novel anti-cancer agents that target the epigenetic reader protein
Technology No. 2021-055
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
Technology No. 20170362
Monoclonal Anti-FAP for cancer research and therapeutic development (2019-131)
Technology No. 2019-131
Antagomir to prevent cardiac arrhythmia (2019-069)
Technology No. 2019-069
Bactericidal Lanbiotic Inhibits Gram-negative Bacteria
Technology No. z07178
Minnesota Solvation (MNSOL) Database
Technology No. 2020-340
Antibody based treatment for Type 1 Diabetes
Technology No. 20180340
Immunostimulatory conjugates for targeted delivery as adjuvants
Technology No. 20180330
Real-Time Reporter and Efficient Enzymes for DNA Editing
Technology No. 20170418
Unique compounds to treat obesity
Technology No. 20170238
Improved Pertussis Vaccine
Technology No. 20160135
Bacterial Biofilms Targeted with Microbial Drone Therapeutics (20140281, Dr. Christine Salomon)
Technology No. 20140281
Dystrophin Gene Targeting Method and Tools (20140040, Dr. Perlingeiro, Dr. Daniel Voytas)
Technology No. 20140040
Long-term whole organ cryopreservation and transplantation
Technology No. 20130131
Mass Spectrometry Software Improves Data Evaluation (20120293, Dr. Timothy Griffin)
Technology No. 20120293
Sarcoma miRNA Expression Database for Cancer Treatment
Technology No. 20090011